Please login to the form below

Not currently logged in
Email:
Password:

Armando Anido appointed CEO of NuPathe

Will lead company as it develops single-use migraine patch

Former Auxilium Pharmaceuticals president and CEO Armando Anido has been appointed as the new CEO of US biopharma NuPathe.

Anido replaces NuPathe's founder Jane Hollingsworth who has resigned from the position two years after being named Ernst & Young's Entrepreneur of the Year.

At the forefront of Anido's tasks will be to lead the company as it develops lead product candidate NP1010 – a single-use transdermal patch for the treatment of migraine.

In addition, NuPathe has two products in development that make use of its long-acting delivery technology that allows delivery of therapeutic levels of medication over a period of months with a single dose.

These comprise NP201 for the continuous symptomatic treatment of Parkinson's disease and NP202, for the long-term treatment of schizophrenia and bipolar disorder.

Anido has more than 30 years' experience in senior biopharma positions, including his five years in charge of Auxilium. Under his leadership, sales grew from $42m in 2005 to more than $260m in 2011.

Prior to this role, Anido served as executive VP, sales and marketing, at MedImmune and prior to that, in senior sales and marketing positions at GlaxoWellcome and Lederle Laboratories.

His time at GlaxoWellcome involved responsibility for the commercialisation of the migraine, epilepsy and depression businesses in the US, setting Anido up well for NuPathe.

"NuPathe has developed a highly innovative and differentiated product for the treatment of migraine," said Anido. "This product innovation, combined with a large population of underserved migraine patients and an outstanding commercial team, builds the foundation required for a successful launch.”

26th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics